Please use this identifier to cite or link to this item:
Scopus Web of Science® Altmetric
Type: Journal article
Title: PRISM: Phase 2 trial with panitumumab monotherapy as second-line treatment in patients with recurrent or metastatic squamous cell carcinoma of the head and neck
Author: Rischin, D.
Spigel, D.
Adkins, D.
Wein, R.
Arnold, S.
Singhal, N.
Lee, O.
Murugappan, S.
Citation: Head and Neck: journal for the sciences and specialities of the head and neck, 2016; 38(S1):E1756-E1761
Publisher: Wiley
Issue Date: 2016
ISSN: 1043-3074
Statement of
Danny Rischin, David R. Spigel, Douglas Adkins, Richard Wein, Susanne Arnold, Nimit Singhal, Oliver Lee, Swami Murugappan
Abstract: Abstract not available
Keywords: recurrent or metastatic squamous cell carcinoma of the head and neck; panitumumab; Panitumumab Regimen In Secondline Monotherapy of Head and Neck Cancer (PRISM) trial; monotherapy; human papillomavirus (HPV); p16
Description: Published online 17 December 2015
Rights: © 2015 Wiley Periodicals, Inc.
DOI: 10.1002/hed.24311
Appears in Collections:Aurora harvest 3
Medicine publications

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.